Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Visiongain | PRODUCT CODE: 1879768

Cover Image

PUBLISHER: Visiongain | PRODUCT CODE: 1879768

Biobanking Market Report 2025-2035

PUBLISHED:
PAGES: 355 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5872.50
PDF (Team License - Up to 6 Users)
USD 6952.50
PDF (Site License)
USD 8167.50
PDF (Enterprise License - Includes Free Datasets)
USD 10320.75

Add to Cart

The global Biobanking market is projected to grow at a CAGR of 8.8% by 2035.

The Biobanking Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Accelerated Market Growth Driven by Multi-Omics and AI Integration

The global biobanking market-valued at US$83.1 billion in 2025 and projected to reach US$194.0 billion by 2035 is accelerating as the sector transitions from conventional sample storage to large-scale, data-rich, multi-omics and AI-enabled research infrastructure. Historically centred on limited academic repositories, biobanks have evolved into globally interconnected platforms managing millions of high-quality samples linked to clinical, genomic, and proteomic datasets. This transformation reflects a broader industry shift toward the active utilisation of biospecimens in sequencing, biomarker discovery, drug development, and translational medicine.

Large national and institutional initiatives-such as advanced proteomic mapping involving hundreds of thousands of samples demonstrate the sector's expanding role. Notably, on 13 January 2025, Illumina announced a pilot proteomics programme analysing 50,000 UK Biobank samples alongside deCODE Genetics, Standard BioTools, Tecan, GSK, Johnson & Johnson, and Novartis, leveraging its next-generation Illumina Protein Prep,N¢ platform. Such collaborations highlight how modern biobanks are becoming critical engines for precision medicine, disease-risk analysis, and long-term population health research, driving robust market expansion.

What would be the Impact of US Trade Tariffs on the Global Biobanking Market?

U.S. trade tariffs are exerting upward pressure on cost structures across the biobanking value chain, particularly for imported ultra-low-temperature freezers, cryogenic systems, automation modules, consumables, and LIMS-related hardware. These cost increases are prompting biobanks to reassess procurement and shift toward regional or tariff-exempt suppliers to maintain budget stability. The tariffs are also slowing infrastructure upgrades, delaying expansion timelines, and constraining capital allocation for advanced automation and digitalisation projects. In response, global suppliers are restructuring manufacturing footprints, while service providers adjust pricing for storage and processing to offset rising costs. Overall, the tariff environment is accelerating trends toward localisation, multi-vendor sourcing, and financially disciplined operational planning across the biobanking sector.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the Biobanking market evolving?
  • What is driving and restraining the Biobanking market?
  • How will each Biobanking submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
  • How will the market shares for each Biobanking submarket develop from 2025 to 2035?
  • What will be the main driver for the overall market from 2025 to 2035?
  • Will leading Biobanking markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the Biobanking projects for these leading companies?
  • How will the industry evolve during the period between 2025 and 2035? What are the implications of
  • Biobanking projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the Biobanking market?
  • Where is the Biobanking market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Biobanking market today, and over the next 10 years:

  • Our 355-page report provides 121 tables and 182 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
  • Forecasts to 2035 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

  • Products and Services
  • Equipment
  • Storage Equipment
  • Sample Analysis Equipment
  • Sample Processing Equipment
  • Sample Transport Equipment
  • Consumables
  • Storage Consumables
  • Analysis Consumables
  • Processing Consumables
  • Collection Consumables
  • Services
  • Storage Services
  • Processing Services
  • Transport Services
  • Supply Services
  • Software
  • Storage Type
  • Automated Storage
  • Manual Storage
  • Ownership
  • National/Regional Agencies
  • Universities
  • Non-profit
  • Private
  • Sample
  • Blood Products
  • Human Tissues
  • Nucleic Acids
  • Cell Lines
  • Biological Fluids
  • Application
  • Regenerative Medicine
  • Life Science Research
  • Clinical Research
  • End-users
  • Pharmaceutical & Biotechnology Companies
  • CROs
  • Academic & Research Institutes
  • Hospitals

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 26 leading national markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Switzerland
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • South-East Asia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America
  • MEA
  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Biobanking Market, 2025 to 2035, with a focus on this segment of these companies' operations.

  • Leading companies and the potential for market growth
  • ASKION GmbH
  • Avantor, Inc.
  • Azenta Inc.
  • BD
  • BioIVT
  • Boca Biolistics
  • Charles River Laboratories International, Inc.
  • Cryoport, Inc.
  • CTIBiotech
  • Hamilton Company
  • ISENET
  • Labcorp
  • Merck KGaA
  • PHC Holdings Corporation
  • ProteoGenex Inc.
  • QIAGEN
  • SciSafe
  • STEMCELL Technologies
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • US Biolab Corporation

Overall world revenue for Biobanking Market, 2025 to 2035 in terms of value the market will surpass US$80.0 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

  • How will the Biobanking Market, 2025 to 2035 report help you?
  • In summary, our 350+ page report provides you with the following knowledge:
  • Revenue forecasts to 2035 for Biobanking Market 2025 to 2035, with forecasts for type and phase, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2035 for five regional and 26 key national markets - See forecasts for the Biobanking Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 22 of the major companies involved in the Biobanking Market, 2025 to 2035.
  • Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
  • Information found nowhere else
  • With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Biobanking Market 2025 to 2035, market-leading companies. You will find data, trends and predictions.
Product Code: PHA1375

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Biobanking Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Increased Focus on Precision Medicine and Genetic Testing
      • 3.2.1.2 Growing Demand for Umbilical Cord Blood Banking
      • 3.2.1.3 Evolution of Biobanks Rapidly Enabling Massive Collections of Biological Materials and Associated Information
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Private Sponsorship Has Raised a Number of Ethical Issues
      • 3.2.2.2 Issues Related to Biospecimen Sample Procurement
      • 3.2.2.3 Long-term Sustainability of Biobanks
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Human Biospecimens are Essential for Progress in Biomarker Discovery and Customised Treatment
      • 3.2.3.2 Opportunities for Cardiovascular Research
      • 3.2.3.3 Growing Focus on the R&D of Cell Therapies
  • 3.3 U.S. Tariffs: What's the Impact on Global Biobanking Market?
    • 3.3.1 Overview
    • 3.3.2 V-Shaped Recovery Scenario
    • 3.3.3 Why V-Shaped Recovery?
      • 3.3.3.1 Impact from Tariffs
      • 3.3.3.2 Market Dynamics and Demand Recovery
      • 3.3.3.3 Policy and Funding Support
      • 3.3.3.4 Timeframe for Recovery
    • 3.3.4 U-Shaped Recovery Scenario
      • 3.3.4.1 Why U-Shaped Recovery?
      • 3.3.4.2 Impact from Tariffs
      • 3.3.4.3 Market Dynamics and Demand Recovery
      • 3.3.4.4 Policy and Funding Support
      • 3.3.4.5 Timeframe for Recovery
    • 3.3.5 L Shaped Recovery Scenario
      • 3.3.5.1 Why L-Shaped Recovery?
      • 3.3.5.2 Impact from Tariffs
      • 3.3.5.3 Market Dynamics and Demand Recovery
      • 3.3.5.4 Policy and Funding Support
      • 3.3.5.5 Timeframe for Recovery
    • 3.3.6 What Strategic Considerations Should Clients Factor into Their Near-term (2025-2030) and Long-term (2025-2035) Planning?
    • 3.3.7 Impact of U.S. and China Trade War on Biobanking Market
    • 3.3.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat of Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Biobanking Market Analysis by Ownership

  • 4.1 Key Findings
  • 4.2 Ownership Segment: Market Attractiveness Index
  • 4.3 Biobanking Market Size Estimation and Forecast by Ownership
  • 4.4 National/Regional Agencies
    • 4.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 4.4.2 Market Share by Region, 2025 & 2035 (%)
  • 4.5 Universities
    • 4.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 4.5.2 Market Share by Region, 2025 & 2035 (%)
  • 4.6 Non-profit
    • 4.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 4.6.2 Market Share by Region, 2025 & 2035 (%)
  • 4.7 Private
    • 4.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 4.7.2 Market Share by Region, 2025 & 2035 (%)

5 Biobanking Market Analysis by Sample

  • 5.1 Key Findings
  • 5.2 Sample Segment: Market Attractiveness Index
  • 5.3 Biobanking Market Size Estimation and Forecast by Sample
  • 5.4 Blood Products
    • 5.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.4.2 Market Share by Region, 2025 & 2035 (%)
  • 5.5 Human Tissues
    • 5.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.5.2 Market Share by Region, 2025 & 2035 (%)
  • 5.6 Nucleic Acids
    • 5.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.6.2 Market Share by Region, 2025 & 2035 (%)
  • 5.7 Cell Lines
    • 5.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.7.2 Market Share by Region, 2025 & 2035 (%)
  • 5.8 Biological Fluids
    • 5.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.8.2 Market Share by Region, 2025 & 2035 (%)
  • 5.9 Others
    • 5.9.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.9.2 Market Share by Region, 2025 & 2035 (%)

6 Biobanking Market Analysis by Application

  • 6.1 Key Findings
  • 6.2 Application Segment: Market Attractiveness Index
  • 6.3 Biobanking Market Size Estimation and Forecast by Application
  • 6.4 Regenerative Medicine
    • 6.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 6.4.2 Market Share by Region, 2025 & 2035 (%)
  • 6.5 Life Science Research
    • 6.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 6.5.2 Market Share by Region, 2025 & 2035 (%)
  • 6.6 Clinical Research
    • 6.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 6.6.2 Market Share by Region, 2025 & 2035 (%)

7 Biobanking Market Analysis by Products and Services

  • 7.1 Key Findings
  • 7.2 Products and Services Segment: Market Attractiveness Index
  • 7.3 Biobanking Market Size Estimation and Forecast by Products and Services
  • 7.4 Equipment
    • 7.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 7.4.2 Market Share by Region, 2025 & 2035 (%)
    • 7.4.3 Equipment Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
      • 7.4.3.1 Storage Equipment
      • 7.4.3.2 Sample Analysis Equipment
      • 7.4.3.3 Sample Processing Equipment
      • 7.4.3.4 Sample Transport Equipment
  • 7.5 Consumables
    • 7.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 7.5.2 Market Share by Region, 2025 & 2035 (%)
    • 7.5.3 Consumables Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
      • 7.5.3.1 Storage Consumables
      • 7.5.3.2 Analysis Consumables
      • 7.5.3.3 Processing Consumables
      • 7.5.3.4 Collection Consumables
  • 7.6 Services
    • 7.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 7.6.2 Market Share by Region, 2025 & 2035 (%)
    • 7.6.3 Services Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
      • 7.6.3.1 Storage Services
      • 7.6.3.2 Processing Services
      • 7.6.3.3 Transport Services
      • 7.6.3.4 Supply Services
  • 7.7 Software
    • 7.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 7.7.2 Market Share by Region, 2025 & 2035 (%)

8 Biobanking Market Analysis by Storage Type

  • 8.1 Key Findings
  • 8.2 Storage Type Segment: Market Attractiveness Index
  • 8.3 Biobanking Market Size Estimation and Forecast by Storage Type
  • 8.4 Automated Storage
    • 8.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 8.4.2 Market Share by Region, 2025 & 2035 (%)
  • 8.5 Manual Storage
    • 8.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 8.5.2 Market Share by Region, 2025 & 2035 (%)

9 Biobanking Market Analysis by End-users

  • 9.1 Key Findings
  • 9.2 End-users Segment: Market Attractiveness Index
  • 9.3 Biobanking Market Size Estimation and Forecast by End-users
  • 9.4 Pharmaceutical & Biotechnology Companies
    • 9.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 9.4.2 Market Share by Region, 2025 & 2035 (%)
  • 9.5 CROs
    • 9.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 9.5.2 Market Share by Region, 2025 & 2035 (%)
  • 9.6 Academic & Research Institutes
    • 9.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 9.6.2 Market Share by Region, 2025 & 2035 (%)
  • 9.7 Hospitals
    • 9.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 9.7.2 Market Share by Region, 2025 & 2035 (%)

10 Biobanking Market Analysis by Region

  • 10.1 Key Findings
  • 10.2 Regional Market Size Estimation and Forecast

11 North America Biobanking Market Analysis

  • 11.1 Key Findings
  • 11.2 North America Biobanking Market Attractiveness Index
  • 11.3 North America Biobanking Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 11.4 North America Biobanking Market Size Estimation and Forecast by Country
  • 11.5 North America Biobanking Market Size Estimation and Forecast by Ownership
  • 11.6 North America Biobanking Market Size Estimation and Forecast by Sample
  • 11.7 North America Biobanking Market Size Estimation and Forecast by Application
  • 11.8 North America Biobanking Market Size Estimation and Forecast by Products and Services
  • 11.9 North America Biobanking Market Size Estimation and Forecast by Storage Type
  • 11.10 North America Biobanking Market Size Estimation and Forecast by End-users
  • 11.11 U.S. Biobanking Market Analysis
  • 11.12 Canada Biobanking Market Analysis

12 Europe Biobanking Market Analysis

  • 12.1 Key Findings
  • 12.2 Europe Biobanking Market Attractiveness Index
  • 12.3 Europe Biobanking Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 12.4 Europe Biobanking Market Size Estimation and Forecast by Country
  • 12.5 Europe Biobanking Market Size Estimation and Forecast by Ownership
  • 12.6 Europe Biobanking Market Size Estimation and Forecast by Sample
  • 12.7 Europe Biobanking Market Size Estimation and Forecast by Application
  • 12.8 Europe Biobanking Market Size Estimation and Forecast by Products and Services
  • 12.9 Europe Biobanking Market Size Estimation and Forecast by Storage Type
  • 12.10 Europe Biobanking Market Size Estimation and Forecast by End-users
  • 12.11 Germany Biobanking Market Analysis
  • 12.12 UK Biobanking Market Analysis
  • 12.13 France Biobanking Market Analysis
  • 12.14 Italy Biobanking Market Analysis
  • 12.15 Spain Biobanking Market Analysis
  • 12.16 Russia Biobanking Market Analysis
  • 12.17 Rest of Europe Biobanking Market Analysis

13 Asia Pacific Biobanking Market Analysis

  • 13.1 Key Findings
  • 13.2 Asia Pacific Biobanking Market Attractiveness Index
  • 13.3 Asia Pacific Biobanking Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 13.4 Asia Pacific Biobanking Market Size Estimation and Forecast by Country
  • 13.5 Asia Pacific Biobanking Market Size Estimation and Forecast by Ownership
  • 13.6 Asia Pacific Biobanking Market Size Estimation and Forecast by Sample
  • 13.7 Asia Pacific Biobanking Market Size Estimation and Forecast by Application
  • 13.8 Asia Pacific Biobanking Market Size Estimation and Forecast by Products and Services
  • 13.9 Asia Pacific Biobanking Market Size Estimation and Forecast by Storage Type
  • 13.10 Asia Pacific Biobanking Market Size Estimation and Forecast by End-users
  • 13.11 Japan Biobanking Market Analysis
  • 13.12 China Biobanking Market Analysis
  • 13.13 India Biobanking Market Analysis
  • 13.14 Australia Biobanking Market Analysis
  • 13.15 South Korea Biobanking Market Analysis
  • 13.16 South-East Asia Biobanking Market Analysis
  • 13.17 Rest of Asia Pacific Biobanking Market Analysis

14 Latin America Biobanking Market Analysis

  • 14.1 Key Findings
  • 14.2 Latin America Biobanking Market Attractiveness Index
  • 14.3 Latin America Biobanking Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 14.4 Latin America Biobanking Market Size Estimation and Forecast by Country
  • 14.5 Latin America Biobanking Market Size Estimation and Forecast by Ownership
  • 14.6 Latin America Biobanking Market Size Estimation and Forecast by Sample
  • 14.7 Latin America Biobanking Market Size Estimation and Forecast by Application
  • 14.8 Latin America Biobanking Market Size Estimation and Forecast by Products and Services
  • 14.9 Latin America Biobanking Market Size Estimation and Forecast by Storage Type
  • 14.10 Latin America Biobanking Market Size Estimation and Forecast by End-users
  • 14.11 Brazil Biobanking Market Analysis
  • 14.12 Mexico Biobanking Market Analysis
  • 14.13 Rest of Latin America Biobanking Market Analysis

15 MEA Biobanking Market Analysis

  • 15.1 Key Findings
  • 15.2 MEA Biobanking Market Attractiveness Index
  • 15.3 MEA Biobanking Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 15.4 MEA Biobanking Market Size Estimation and Forecast by Country
  • 15.5 MEA Biobanking Market Size Estimation and Forecast by Ownership
  • 15.6 MEA Biobanking Market Size Estimation and Forecast by Sample
  • 15.7 MEA Biobanking Market Size Estimation and Forecast by Application
  • 15.8 MEA Biobanking Market Size Estimation and Forecast by Products and Services
  • 15.9 MEA Biobanking Market Size Estimation and Forecast by Storage Type
  • 15.10 MEA Biobanking Market Size Estimation and Forecast by End-users
  • 15.11 GCC Biobanking Market Analysis
  • 15.12 South Africa Biobanking Market Analysis
  • 15.13 Rest of MEA Biobanking Market Analysis

16 Company Profiles

  • 16.1 Thermo Fisher Scientific Inc.
    • 16.1.1 Company Snapshot
    • 16.1.2 Company Overview
    • 16.1.3 Financial Analysis
      • 16.1.3.1 Net Revenue, 2020-2024
      • 16.1.3.2 Regional Market Shares, 2024
      • 16.1.3.3 R&D, 2020-2024
    • 16.1.4 Product Benchmarking
  • 16.2 PHC Holdings Corporation
    • 16.2.1 Company Snapshot
    • 16.2.2 Company Overview
    • 16.2.3 Product Benchmarking
    • 16.2.4 Strategic Outlook
  • 16.3 Hamilton Company
    • 16.3.1 Company Snapshot
    • 16.3.2 Company Overview
    • 16.3.3 Product Benchmarking
  • 16.4 Avantor Inc.
    • 16.4.1 Company Snapshot
    • 16.4.2 Company Overview
    • 16.4.3 Financial Analysis
      • 16.4.3.1 Net Revenue, 2020-2024
      • 16.4.3.2 Regional Market Shares, 2024
    • 16.4.4 Product Benchmarking
  • 16.5 QIAGEN
    • 16.5.1 Company Snapshot
    • 16.5.2 Company Overview
    • 16.5.3 Financial Analysis
      • 16.5.3.1 Net Revenue, 2020-2024
      • 16.5.3.2 Regional Market Shares, 2024
      • 16.5.3.3 R&D, 2020-2024
    • 16.5.4 Product Benchmarking
  • 16.6 Tecan Trading AG
    • 16.6.1 Company Snapshot
    • 16.6.2 Company Overview
    • 16.6.3 Product Benchmarking
  • 16.7 Merck KGaA
    • 16.7.1 Company Snapshot
    • 16.7.2 Company Overview
    • 16.7.3 Financial Analysis
      • 16.7.3.1 Net Revenue, 2020-2024
      • 16.7.3.2 Regional Market Shares, 2024
      • 16.7.3.3 R&D, 2020-2024
    • 16.7.4 Product Benchmarking
  • 16.8 Cryoport, Inc.
    • 16.8.1 Company Snapshot
    • 16.8.2 Company Overview
    • 16.8.3 Financial Analysis
      • 16.8.3.1 Net Revenue, 2020-2024
      • 16.8.3.2 Regional Market Shares, 2024
      • 16.8.3.3 R&D, 2020-2024
    • 16.8.4 Product Benchmarking
    • 16.8.5 Strategic Outlook
  • 16.9 Azenta Inc.
    • 16.9.1 Company Snapshot
    • 16.9.2 Company Overview
    • 16.9.3 Financial Analysis
      • 16.9.3.1 Net Revenue, 2020-2024
      • 16.9.3.2 R&D, 2020-2024
    • 16.9.4 Product Benchmarking
  • 16.10 ISENET
    • 16.10.1 Company Snapshot
    • 16.10.2 Company Overview
    • 16.10.3 Product Benchmarking
  • 16.11 CTIBiotech
    • 16.11.1 Company Snapshot
    • 16.11.2 Company Overview
    • 16.11.3 Product Benchmarking
  • 16.12 Boca Biolistics
    • 16.12.1 Company Snapshot
    • 16.12.2 Company Overview
    • 16.12.3 Product Benchmarking
    • 16.12.4 Strategic Outlook
  • 16.13 BIOIVT
    • 16.13.1 Company Snapshot
    • 16.13.2 Company Overview
    • 16.13.3 Product Benchmarking
    • 16.13.4 Strategic Outlook
  • 16.14 US Biolab Corporation
    • 16.14.1 Company Snapshot
    • 16.14.2 Company Overview
    • 16.14.3 Product Benchmarking
  • 16.15 ProteoGenex Inc.
    • 16.15.1 Company Snapshot
    • 16.15.2 Company Overview
    • 16.15.3 Product Benchmarking
  • 16.16 ASKION GmbH
    • 16.16.1 Company Snapshot
    • 16.16.2 Company Overview
    • 16.16.3 Product Benchmarking
  • 16.17 STEMCELL Technologies
    • 16.17.1 Company Snapshot
    • 16.17.2 Company Overview
    • 16.17.3 Product Benchmarking
    • 16.17.4 Strategic Outlook
  • 16.18 SciSafe
    • 16.18.1 Company Snapshot
    • 16.18.2 Company Overview
    • 16.18.3 Product Benchmarking
  • 16.19 Charles River Laboratories International, Inc.
    • 16.19.1 Company Snapshot
    • 16.19.2 Company Overview
    • 16.19.3 Financial Analysis
      • 16.19.3.1 Net Revenue, 2020-2024
      • 16.19.3.2 Regional Market Shares, 2024
    • 16.19.4 Product Benchmarking
    • 16.19.5 Strategic Outlook
  • 16.20 BD
    • 16.20.1 Company Snapshot
    • 16.20.2 Company Overview
    • 16.20.3 Financial Analysis
      • 16.20.3.1 Net Revenue, 2020-2024
      • 16.20.3.2 Regional Market Shares, 2024
      • 16.20.3.3 R&D, 2020-2024
    • 16.20.4 Product Benchmarking
  • 16.21 Labcorp
    • 16.21.1 Company Snapshot
    • 16.21.2 Company Overview
    • 16.21.3 Financial Analysis
      • 16.21.3.1 Net Revenue, 2020-2024
      • 16.21.3.2 Regional Market Shares, 2024
    • 16.21.4 Product Benchmarking

17 Conclusion and Recommendations

  • 17.1 Concluding Remarks from Visiongain
  • 17.2 Recommendations for Market Players
Product Code: PHA1375

List of Tables

  • Table 1 Biobanking Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
  • Table 2 Biobanking Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 3 Biobanking Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): U Shaped Recovery
  • Table 4 Biobanking Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): L Shaped Recovery
  • Table 5 Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 6 National/ Regional Agencies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 7 Universities Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 8 Non-profit Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 9 Private Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 10 Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 11 Blood Products Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 12 Human Tissues Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 13 Nucleic Acid Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 14 Cell Lines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 15 Biological Fluids Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 16 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 17 Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 18 Regenerative Medicine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 19 Life Science Research Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 20 Clinical Research Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 21 Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 22 Equipment Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 23 Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 24 Consumables Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 25 Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 26 Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 27 Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 28 Software Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 29 Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 30 Automated Storage Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 31 Manual Storage Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 32 Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 33 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 34 CROs Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 35 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 36 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 37 Biobanking Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 38 North America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 39 North America Biobanking Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 40 North America Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 41 North America Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 42 North America Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 43 North America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 44 North America Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 45 U.S. Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 46 Canada Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 47 Europe Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 48 Europe Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 49 Europe Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 50 Europe Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 51 Europe Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 52 Europe Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 53 Europe Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 54 Germany Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 55 UK Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 56 France Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 57 Italy Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 58 Spain Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 59 Russia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 60 Rest of Europe Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 61 Asia Pacific Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 62 Asia Pacific Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 63 Asia Pacific Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 64 Asia Pacific Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 65 Asia Pacific Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 66 Asia Pacific Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 67 Asia Pacific Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 68 Japan Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 69 China Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 70 India Biobanking Institutes
  • Table 71 India Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 72 Australia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 73 South Korea Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 74 South-East Asia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 75 Rest of Asia Pacific Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 76 Latin America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 77 Latin America Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 78 Latin America Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 79 Latin America Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 80 Latin America Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 81 Latin America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 82 Latin America Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 83 Brazil Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 84 Mexico Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 85 Rest of Latin America Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 86 MEA Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 87 MEA Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 88 MEA Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 89 MEA Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 90 MEA Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 91 MEA Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 92 MEA Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 93 GCC Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 94 South Africa Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 95 Rest of MEA Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 96 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 97 Thermo Fisher Scientific Inc.: Product Benchmarking
  • Table 98 PHC Holdings Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 99 PHC Holdings Corporation: Product Benchmarking
  • Table 100 PHC Holdings Corporation: Strategic Outlook
  • Table 101 Hamilton Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 Hamilton Company: Product Benchmarking
  • Table 103 Avantor Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 104 Avantor Inc.: Product Benchmarking
  • Table 105 QIAGEN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 106 QIAGEN: Product Benchmarking
  • Table 107 Tecan Trading AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 108 Tecan Trading AG: Product Benchmarking
  • Table 109 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 110 Merck KGaA: Product Benchmarking
  • Table 111 Cryoport, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 112 Cryoport, Inc.: Product Benchmarking
  • Table 113 Cryoport, Inc.: Strategic Outlook
  • Table 114 Azenta Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 115 Azenta Inc.: Product Benchmarking
  • Table 116 ISENET: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 117 ISENET: Product Benchmarking
  • Table 118 CTIBiotech: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 119 CTIBiotech: Product Benchmarking
  • Table 120 Boca Biolistics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 121 Boca Biolistics: Product Benchmarking
  • Table 122 Boca Biolistics: Strategic Outlook
  • Table 123 BIOIVT: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 124 BIOIVT: Product Benchmarking
  • Table 125 BIOIVT: Strategic Outlook
  • Table 126 US Biolab Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 127 US Biolab Corporation: Product Benchmarking
  • Table 128 ProteoGenex Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 129 ProteoGenex Inc.: Product Benchmarking
  • Table 130 ASKION GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 131 ASKION GmbH: Product Benchmarking
  • Table 132 STEMCELL Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 133 STEMCELL Technologies: Product Benchmarking
  • Table 134 STEMCELL Technologies: Strategic Outlook
  • Table 135 SciSafe: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 136 SciSafe: Product Benchmarking
  • Table 137 Charles River Laboratories International, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 138 Charles River Laboratories International, Inc.: Product Benchmarking
  • Table 139 Charles River Laboratories International, Inc.: Strategic Outlook
  • Table 140 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 141 BD: Product Benchmarking
  • Table 142 Labcorp: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 143 Labcorp: Product Benchmarking

List of Figures

  • Figure 1 Biobanking Market Segmentation
  • Figure 2 Biobanking Market by Ownership: Market Attractiveness Index
  • Figure 3 Biobanking Market by Sample: Market Attractiveness Index
  • Figure 4 Biobanking Market by Application: Market Attractiveness Index
  • Figure 5 Biobanking Market by Products and Services: Market Attractiveness Index
  • Figure 6 Biobanking Market by End-users: Market Attractiveness Index
  • Figure 7 Biobanking Market Attractiveness Index by Region
  • Figure 8 Biobanking Market: Market Dynamics
  • Figure 1 Biobanking Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
  • Figure 2 Biobanking Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
  • Figure 3 Biobanking Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
  • Figure 4 Short Term & Long Term Planning
  • Figure 5 Impact of U.S. and China Trade War
  • Figure 6 Most Impacted Countries
  • Figure 7 Biobanking Market: Porter's Five Forces Analysis
  • Figure 8 Biobanking Market: PEST Analysis
  • Figure 9 Biobanking Market Attractiveness Index by Ownership
  • Figure 10 Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
  • Figure 11 Biobanking Market Share Forecast by Ownership, 2025, 2030, 2035 (%)
  • Figure 12 National/Regional Agencies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 13 National/Regional Agencies Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 14 Universities Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 15 Universities Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 16 Non-profit Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 17 Non-profit Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 18 Private Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 19 Private Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 20 Biobanking Market Attractiveness Index by Ownership
  • Figure 21 Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
  • Figure 22 Biobanking Market Share Forecast by Sample, 2025, 2030, 2035 (%)
  • Figure 23 Blood Products Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 24 Blood Products Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 25 Human Tissues Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 26 Human Tissues Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 27 Nucleic Acids Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 28 Nucleic Acids Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 29 Cell Lines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 30 Cell Lines Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 31 Biological Fluids Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 32 Biological Fluids Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 33 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 34 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 35 Biobanking Market Attractiveness Index by Application
  • Figure 36 Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 37 Biobanking Market Share Forecast by Application, 2025, 2030, 2035 (%)
  • Figure 38 Regenerative Medicine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 39 Regenerative Medicine Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 40 Life Science Research Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 41 Life Science Research Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 42 Clinical Research Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 43 Clinical Research Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 44 Biobanking Market Attractiveness Index by Products and Services
  • Figure 45 Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
  • Figure 46 Biobanking Market Share Forecast by Products and Services, 2025, 2030, 2035 (%)
  • Figure 47 Equipment Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 48 Equipment Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 49 Equipment Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 50 Consumables Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 51 Consumables Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 52 Consumables Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 53 Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 54 Services Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 55 Services Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 56 Software Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 57 Software Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 58 Biobanking Market Attractiveness Index by Storage Type
  • Figure 59 Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 60 Biobanking Market Share Forecast by Storage Type, 2025, 2030, 2035 (%)
  • Figure 61 Automated Storage Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 62 Automated Storage Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 63 Manual Storage Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 64 Manual Storage Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 65 Biobanking Market Attractiveness Index by End-users
  • Figure 66 Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 67 Biobanking Market Share Forecast by End-users, 2025, 2030, 2035 (%)
  • Figure 68 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 69 Pharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 70 CROs Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 71 CROs Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 72 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 73 Academic & Research Institutes Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 74 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 75 Hospitals Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 76 Biobanking Market Forecast by Region 2025, 2030, 2035 (Revenue, CAGR%)
  • Figure 77 Biobanking Market Share Forecast by Region 2025, 2030, 2035 (%)
  • Figure 78 Biobanking Market by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 79 North America Biobanking Market Attractiveness Index
  • Figure 80 North America Biobanking Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 81 North America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion)
  • Figure 82 North America Biobanking Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 83 North America Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
  • Figure 84 North America Biobanking Market Share Forecast by Ownership, 2025 & 2035 (%)
  • Figure 85 North America Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
  • Figure 86 North America Biobanking Market Share Forecast by Sample, 2025 & 2035 (%)
  • Figure 87 North America Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 88 North America Biobanking Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 89 North America Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
  • Figure 90 North America Biobanking Market Share Forecast by Products and Services, 2025 & 2035 (%)
  • Figure 91 North America Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 92 North America Biobanking Market Share Forecast by Storage Type, 2025 & 2035 (%)
  • Figure 93 North America Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 94 North America Biobanking Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 95 U.S. Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 96 Canada Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 97 Europe Biobanking Market Attractiveness Index
  • Figure 98 Europe Biobanking Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 99 Europe Biobanking Market Forecast by Country, 2025-2035 (US$ Billion)
  • Figure 100 Europe Biobanking Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 101 Europe Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
  • Figure 102 Europe Biobanking Market Share Forecast by Ownership, 2025 & 2035 (%)
  • Figure 103 Europe Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
  • Figure 104 Europe Biobanking Market Share Forecast by Sample, 2025 & 2035 (%)
  • Figure 105 Europe Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 106 Europe Biobanking Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 107 Europe Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
  • Figure 108 Europe Biobanking Market Share Forecast by Products and Services, 2025 & 2035 (%)
  • Figure 109 Europe Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 110 Europe Biobanking Market Share Forecast by Storage Type, 2025 & 2035 (%)
  • Figure 111 Europe Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 112 Europe Biobanking Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 113 Germany Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 114 UK Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 115 France Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 116 Italy Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 117 Spain Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 118 Russia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 119 Rest of Europe Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 120 Asia Pacific Biobanking Market Attractiveness Index
  • Figure 121 Asia Pacific Biobanking Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 122 Asia Pacific Biobanking Market Forecast by Country, 2025-2035 (US$ Billion)
  • Figure 123 Asia Pacific Biobanking Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 124 Asia Pacific Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
  • Figure 125 Asia Pacific Biobanking Market Share Forecast by Ownership, 2025 & 2035 (%)
  • Figure 126 Asia Pacific Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
  • Figure 127 Asia Pacific Biobanking Market Share Forecast by Sample, 2025 & 2035 (%)
  • Figure 128 Asia Pacific Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 129 Asia Pacific Biobanking Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 130 Asia Pacific Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
  • Figure 131 Asia Pacific Biobanking Market Share Forecast by Products and Services, 2025 & 2035 (%)
  • Figure 132 Asia Pacific Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 133 Asia Pacific Biobanking Market Share Forecast by Storage Type, 2025 & 2035 (%)
  • Figure 134 Asia Pacific Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 135 Asia Pacific Biobanking Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 136 Japan Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 137 China Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 138 India Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 139 Australia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 140 South Korea Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 141 South-East Asia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 142 Rest of Asia Pacific Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 143 Latin America Biobanking Market Attractiveness Index
  • Figure 144 Latin America Biobanking Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 145 Latin America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion)
  • Figure 146 Latin America Biobanking Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 147 Latin America Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
  • Figure 148 Latin America Biobanking Market Share Forecast by Ownership, 2025 & 2035 (%)
  • Figure 149 Latin America Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
  • Figure 150 Latin America Biobanking Market Share Forecast by Sample, 2025 & 2035 (%)
  • Figure 151 Latin America Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 152 Latin America Biobanking Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 153 Latin America Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
  • Figure 154 Latin America Biobanking Market Share Forecast by Products and Services, 2025 & 2035 (%)
  • Figure 155 Latin America Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 156 Latin America Biobanking Market Share Forecast by Storage Type, 2025 & 2035 (%)
  • Figure 157 Latin America Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 158 Latin America Biobanking Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 159 Brazil Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 160 Mexico Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 161 Rest of Latin America Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 162 MEA Biobanking Market Attractiveness Index
  • Figure 163 MEA Biobanking Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 164 MEA Biobanking Market Forecast by Country, 2025-2035 (US$ Billion)
  • Figure 165 MEA Biobanking Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 166 MEA Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
  • Figure 167 MEA Biobanking Market Share Forecast by Ownership, 2025 & 2035 (%)
  • Figure 168 MEA Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
  • Figure 169 MEA Biobanking Market Share Forecast by Sample, 2025 & 2035 (%)
  • Figure 170 MEA Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 171 MEA Biobanking Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 172 MEA Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
  • Figure 173 MEA Biobanking Market Share Forecast by Products and Services, 2025 & 2035 (%)
  • Figure 174 MEA Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 175 MEA Biobanking Market Share Forecast by Storage Type, 2025 & 2035 (%)
  • Figure 176 MEA Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 177 MEA Biobanking Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 178 GCC Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 179 South Africa Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 180 Rest of MEA Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 181 Thermo Fisher Scientific Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
  • Figure 182 Thermo Fisher Scientific Inc.: Regional Market Shares (%), 2024
  • Figure 183 Thermo Fisher Scientific Inc.: R&D, 2020-2024 (US$ Million, AGR%)
  • Figure 184 Avantor Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
  • Figure 185 Avantor Inc.: Regional Market Shares (%), 2024
  • Figure 186 QIAGEN: Net Revenue, 2020-2024 (US$ Million, AGR%)
  • Figure 187 QIAGEN: Regional Market Shares (%), 2024
  • Figure 188 QIAGEN: R&D, 2020-2024 (US$ Million, AGR%)
  • Figure 189 Merck KGaA: Net Revenue, 2020-2024 (US$ Million, AGR%)
  • Figure 190 Merck KGaA: Regional Market Shares (%), 2024
  • Figure 191 Merck KGaA: R&D, 2020-2024 (US$ Million, AGR%)
  • Figure 192 Cryoport, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
  • Figure 193 Cryoport, Inc.: Regional Market Shares (%), 2024
  • Figure 194 Cryoport, Inc.: R&D, 2020-2024 (US$ Million, AGR%)
  • Figure 195 Azenta Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
  • Figure 196 Azenta Inc.: R&D, 2020-2024 (US$ Million, AGR%)
  • Figure 197 Charles River Laboratories International, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
  • Figure 198 Charles River Laboratories International, Inc.: Regional Market Shares (%), 2024
  • Figure 199 BD: Net Revenue, 2020-2024 (US$ Million, AGR%)
  • Figure 200 BD: Regional Market Shares (%), 2024
  • Figure 201 BD: R&D, 2020-2024 (US$ Million, AGR%)
  • Figure 202 Labcorp: Net Revenue, 2020-2024 (US$ Million, AGR%)
  • Figure 203 Labcorp: Regional Market Shares (%), 2024
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!